Tekla Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | $70.6M | Buy |
|
|||||
2023
Q1 | $67M | Buy |
|
|||||
2022
Q4 | $54.1M | Buy |
|
|||||
2022
Q3 | $38.8M | Buy |
|
|||||
2022
Q2 | $27.7M | Hold |
|
|||||
2022
Q1 | $28.6M | Hold |
|
|||||
2021
Q4 | $32.5M | Sell |
|
|||||
2021
Q3 | $66.2M | Buy |
|
|||||
2021
Q2 | $72.4M | Sell |
|
|||||
2021
Q1 | $69.1M | Hold |
|
|||||
2020
Q4 | $60.4M | Buy |
|
|||||
2020
Q3 | $60.6M | Sell |
|
|||||
2020
Q2 | $62.5M | Sell |
|
|||||
2020
Q1 | $105M | Buy |
|
|||||
2019
Q4 | $84.6M | Buy |
|
|||||
2019
Q3 | $60.1M | Buy |
|
|||||
2019
Q2 | $52.5M | Sell |
|
|||||
2019
Q1 | $74.3M | Sell |
|
|||||
2018
Q4 | $119M | Buy |
|
|||||
2018
Q3 | $138M | Sell |
|
|||||
2018
Q2 | $117M | Buy |
|
|||||
2018
Q1 | $104M | Sell |
|
|||||
2017
Q4 | $142M | Sell |
|
|||||
2017
Q3 | $153M | Sell |
|
|||||
2017
Q2 | $144M | Buy |
|
|||||
2017
Q1 | $133M | Sell |
|
|||||
2016
Q4 | $152M | Buy |
|
|||||
2016
Q3 | $151M | Buy |
|
|||||
2016
Q2 | $109M | Hold |
|
|||||
2016
Q1 | $117M | Hold |
|
|||||
2015
Q4 | $138M | Sell |
|
|||||
2015
Q3 | $136M | Buy |
|
|||||
2015
Q2 | $143M | Buy |
|
|||||
2015
Q1 | $143M | Buy |
|
|||||
2014
Q4 | $111M | Buy |
|
|||||
2014
Q3 | $61.8M | Buy |
|
|||||
2014
Q2 | $54.9M | Hold |
|
|||||
2014
Q1 | $53.2M | Sell |
|
|||||
2013
Q4 | $53.7M | Hold |
|
|||||
2013
Q3 | $46.2M | Hold |
|
|||||
2013
Q2 | $41.3M | Buy |
|